Legend Biotech (LEGN) Shares Outstanding (Diluted Average) (2019 - 2025)
Legend Biotech (LEGN) posted Shares Outstanding (Diluted Average) of $810.0 for Q4 2025, up 12.5% on a QoQ basis from $720.0 in Q3 2025, and up 68.75% year-over-year from $480.0 in Q4 2024.
Legend Biotech (LEGN) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $810.0 in Q4 2025.
- In Q4 2025, Shares Outstanding (Diluted Average) rose 68.75% year-over-year to $810.0; the TTM figure through Dec 2025 stood at $810.0 (up 68.75% YoY), while the FY2025 annual figure was $810.0, up 68.75% from the prior year.
- Shares Outstanding (Diluted Average) improved to $810.0 in Q4 2025, from $720.0 in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $308.7 million in Q1 2022 and bottomed at $210.0 in Q2 2024.
- A 4-year average of $106.3 million and a median of $810.0 in 2025 frame the typical range for Shares Outstanding (Diluted Average).
- Annual changes were most pronounced in 2021 — Shares Outstanding (Diluted Average) tumbled 99.87% — and 2022, when it soared 115824.18%.
- Year by year, Shares Outstanding (Diluted Average) stood at $293.2 million in 2021, then grew by 5.29% to $308.7 million in 2022, then tumbled by 100.0% to $480.0 in 2024, then surged by 68.75% to $810.0 in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $810.0 (Q4 2025), $720.0 (Q3 2025), and $620.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.06 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 810.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 256.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 138.23 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 198.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 810.00 |
| Sep 30, 2025 | 720.00 |
| Jun 30, 2025 | 620.00 |
| Dec 31, 2024 | 480.00 |
| Sep 30, 2024 | 560.00 |
| Jun 30, 2024 | 210.00 |
| Mar 31, 2022 | 308.70 Mn |
| Dec 31, 2021 | 293.20 Mn |
| Sep 30, 2021 | 289.92 Mn |
| Jun 30, 2021 | 277.02 Mn |
| Mar 31, 2021 | 266,293.91 |
| Dec 31, 2020 | 264.72 Mn |
| Sep 30, 2020 | 264.33 Mn |
| Jun 30, 2020 | 215.55 Mn |
| Mar 31, 2020 | 200.00 Mn |
| Dec 31, 2019 | 200.00 Mn |
| Sep 30, 2019 | 200.00 Mn |
| Jun 30, 2019 | 200.00 Mn |